Request for Covid-19 Impact Assessment of this Report
The United States Roxatidine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Roxatidine market, reaching US$ million by the year 2028. As for the Europe Roxatidine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Roxatidine players cover Sanofi Aventis, Sihuan Pharmaceutical, Sun Pharmaceutical, and Taj Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Roxatidine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injectable
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acidity
Heartburn
Intestinal Ulcers
Stomach Ulcers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Aventis
Sihuan Pharmaceutical
Sun Pharmaceutical
Taj Pharmaceuticals
Shin Poong Pharmaceuticals
Sawai Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Roxatidine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Roxatidine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Roxatidine by Country/Region, 2017, 2022 & 2028
2.2 Roxatidine Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.3 Roxatidine Sales by Type
2.3.1 Global Roxatidine Sales Market Share by Type (2017-2022)
2.3.2 Global Roxatidine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Roxatidine Sale Price by Type (2017-2022)
2.4 Roxatidine Segment by Application
2.4.1 Acidity
2.4.2 Heartburn
2.4.3 Intestinal Ulcers
2.4.4 Stomach Ulcers
2.4.5 Others
2.5 Roxatidine Sales by Application
2.5.1 Global Roxatidine Sale Market Share by Application (2017-2022)
2.5.2 Global Roxatidine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Roxatidine Sale Price by Application (2017-2022)
3 Global Roxatidine by Company
3.1 Global Roxatidine Breakdown Data by Company
3.1.1 Global Roxatidine Annual Sales by Company (2020-2022)
3.1.2 Global Roxatidine Sales Market Share by Company (2020-2022)
3.2 Global Roxatidine Annual Revenue by Company (2020-2022)
3.2.1 Global Roxatidine Revenue by Company (2020-2022)
3.2.2 Global Roxatidine Revenue Market Share by Company (2020-2022)
3.3 Global Roxatidine Sale Price by Company
3.4 Key Manufacturers Roxatidine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Roxatidine Product Location Distribution
3.4.2 Players Roxatidine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Roxatidine by Geographic Region
4.1 World Historic Roxatidine Market Size by Geographic Region (2017-2022)
4.1.1 Global Roxatidine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Roxatidine Annual Revenue by Geographic Region
4.2 World Historic Roxatidine Market Size by Country/Region (2017-2022)
4.2.1 Global Roxatidine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Roxatidine Annual Revenue by Country/Region
4.3 Americas Roxatidine Sales Growth
4.4 APAC Roxatidine Sales Growth
4.5 Europe Roxatidine Sales Growth
4.6 Middle East & Africa Roxatidine Sales Growth
5 Americas
5.1 Americas Roxatidine Sales by Country
5.1.1 Americas Roxatidine Sales by Country (2017-2022)
5.1.2 Americas Roxatidine Revenue by Country (2017-2022)
5.2 Americas Roxatidine Sales by Type
5.3 Americas Roxatidine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Roxatidine Sales by Region
6.1.1 APAC Roxatidine Sales by Region (2017-2022)
6.1.2 APAC Roxatidine Revenue by Region (2017-2022)
6.2 APAC Roxatidine Sales by Type
6.3 APAC Roxatidine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Roxatidine by Country
7.1.1 Europe Roxatidine Sales by Country (2017-2022)
7.1.2 Europe Roxatidine Revenue by Country (2017-2022)
7.2 Europe Roxatidine Sales by Type
7.3 Europe Roxatidine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Roxatidine by Country
8.1.1 Middle East & Africa Roxatidine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Roxatidine Revenue by Country (2017-2022)
8.2 Middle East & Africa Roxatidine Sales by Type
8.3 Middle East & Africa Roxatidine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roxatidine
10.3 Manufacturing Process Analysis of Roxatidine
10.4 Industry Chain Structure of Roxatidine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Roxatidine Distributors
11.3 Roxatidine Customer
12 World Forecast Review for Roxatidine by Geographic Region
12.1 Global Roxatidine Market Size Forecast by Region
12.1.1 Global Roxatidine Forecast by Region (2023-2028)
12.1.2 Global Roxatidine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Roxatidine Forecast by Type
12.7 Global Roxatidine Forecast by Application
13 Key Players Analysis
13.1 Sanofi Aventis
13.1.1 Sanofi Aventis Company Information
13.1.2 Sanofi Aventis Roxatidine Product Offered
13.1.3 Sanofi Aventis Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Aventis Main Business Overview
13.1.5 Sanofi Aventis Latest Developments
13.2 Sihuan Pharmaceutical
13.2.1 Sihuan Pharmaceutical Company Information
13.2.2 Sihuan Pharmaceutical Roxatidine Product Offered
13.2.3 Sihuan Pharmaceutical Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sihuan Pharmaceutical Main Business Overview
13.2.5 Sihuan Pharmaceutical Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Roxatidine Product Offered
13.3.3 Sun Pharmaceutical Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Taj Pharmaceuticals
13.4.1 Taj Pharmaceuticals Company Information
13.4.2 Taj Pharmaceuticals Roxatidine Product Offered
13.4.3 Taj Pharmaceuticals Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Taj Pharmaceuticals Main Business Overview
13.4.5 Taj Pharmaceuticals Latest Developments
13.5 Shin Poong Pharmaceuticals
13.5.1 Shin Poong Pharmaceuticals Company Information
13.5.2 Shin Poong Pharmaceuticals Roxatidine Product Offered
13.5.3 Shin Poong Pharmaceuticals Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shin Poong Pharmaceuticals Main Business Overview
13.5.5 Shin Poong Pharmaceuticals Latest Developments
13.6 Sawai Pharmaceutical
13.6.1 Sawai Pharmaceutical Company Information
13.6.2 Sawai Pharmaceutical Roxatidine Product Offered
13.6.3 Sawai Pharmaceutical Roxatidine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sawai Pharmaceutical Main Business Overview
13.6.5 Sawai Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Roxatidine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Roxatidine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Global Roxatidine Sales by Type (2017-2022) & (K Units)
Table 6. Global Roxatidine Sales Market Share by Type (2017-2022)
Table 7. Global Roxatidine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Roxatidine Revenue Market Share by Type (2017-2022)
Table 9. Global Roxatidine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Roxatidine Sales by Application (2017-2022) & (K Units)
Table 11. Global Roxatidine Sales Market Share by Application (2017-2022)
Table 12. Global Roxatidine Revenue by Application (2017-2022)
Table 13. Global Roxatidine Revenue Market Share by Application (2017-2022)
Table 14. Global Roxatidine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Roxatidine Sales by Company (2020-2022) & (K Units)
Table 16. Global Roxatidine Sales Market Share by Company (2020-2022)
Table 17. Global Roxatidine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Roxatidine Revenue Market Share by Company (2020-2022)
Table 19. Global Roxatidine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Roxatidine Producing Area Distribution and Sales Area
Table 21. Players Roxatidine Products Offered
Table 22. Roxatidine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Roxatidine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Roxatidine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Roxatidine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Roxatidine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Roxatidine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Roxatidine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Roxatidine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Roxatidine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Roxatidine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Roxatidine Sales Market Share by Country (2017-2022)
Table 35. Americas Roxatidine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Roxatidine Revenue Market Share by Country (2017-2022)
Table 37. Americas Roxatidine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Roxatidine Sales Market Share by Type (2017-2022)
Table 39. Americas Roxatidine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Roxatidine Sales Market Share by Application (2017-2022)
Table 41. APAC Roxatidine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Roxatidine Sales Market Share by Region (2017-2022)
Table 43. APAC Roxatidine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Roxatidine Revenue Market Share by Region (2017-2022)
Table 45. APAC Roxatidine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Roxatidine Sales Market Share by Type (2017-2022)
Table 47. APAC Roxatidine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Roxatidine Sales Market Share by Application (2017-2022)
Table 49. Europe Roxatidine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Roxatidine Sales Market Share by Country (2017-2022)
Table 51. Europe Roxatidine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Roxatidine Revenue Market Share by Country (2017-2022)
Table 53. Europe Roxatidine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Roxatidine Sales Market Share by Type (2017-2022)
Table 55. Europe Roxatidine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Roxatidine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Roxatidine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Roxatidine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Roxatidine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Roxatidine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Roxatidine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Roxatidine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Roxatidine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Roxatidine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Roxatidine
Table 66. Key Market Challenges & Risks of Roxatidine
Table 67. Key Industry Trends of Roxatidine
Table 68. Roxatidine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Roxatidine Distributors List
Table 71. Roxatidine Customer List
Table 72. Global Roxatidine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Roxatidine Sales Market Forecast by Region
Table 74. Global Roxatidine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Roxatidine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Roxatidine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Roxatidine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Roxatidine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Roxatidine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Roxatidine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Roxatidine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Roxatidine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Roxatidine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Roxatidine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Roxatidine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Roxatidine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Roxatidine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Roxatidine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Roxatidine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Roxatidine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Roxatidine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Aventis Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Aventis Roxatidine Product Offered
Table 94. Sanofi Aventis Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Aventis Main Business
Table 96. Sanofi Aventis Latest Developments
Table 97. Sihuan Pharmaceutical Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sihuan Pharmaceutical Roxatidine Product Offered
Table 99. Sihuan Pharmaceutical Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Sihuan Pharmaceutical Main Business
Table 101. Sihuan Pharmaceutical Latest Developments
Table 102. Sun Pharmaceutical Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Roxatidine Product Offered
Table 104. Sun Pharmaceutical Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Sun Pharmaceutical Main Business
Table 106. Sun Pharmaceutical Latest Developments
Table 107. Taj Pharmaceuticals Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 108. Taj Pharmaceuticals Roxatidine Product Offered
Table 109. Taj Pharmaceuticals Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Taj Pharmaceuticals Main Business
Table 111. Taj Pharmaceuticals Latest Developments
Table 112. Shin Poong Pharmaceuticals Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 113. Shin Poong Pharmaceuticals Roxatidine Product Offered
Table 114. Shin Poong Pharmaceuticals Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Shin Poong Pharmaceuticals Main Business
Table 116. Shin Poong Pharmaceuticals Latest Developments
Table 117. Sawai Pharmaceutical Basic Information, Roxatidine Manufacturing Base, Sales Area and Its Competitors
Table 118. Sawai Pharmaceutical Roxatidine Product Offered
Table 119. Sawai Pharmaceutical Roxatidine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Sawai Pharmaceutical Main Business
Table 121. Sawai Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Roxatidine
Figure 2. Roxatidine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Roxatidine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Roxatidine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Roxatidine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injectable
Figure 11. Global Roxatidine Sales Market Share by Type in 2021
Figure 12. Global Roxatidine Revenue Market Share by Type (2017-2022)
Figure 13. Roxatidine Consumed in Acidity
Figure 14. Global Roxatidine Market: Acidity (2017-2022) & (K Units)
Figure 15. Roxatidine Consumed in Heartburn
Figure 16. Global Roxatidine Market: Heartburn (2017-2022) & (K Units)
Figure 17. Roxatidine Consumed in Intestinal Ulcers
Figure 18. Global Roxatidine Market: Intestinal Ulcers (2017-2022) & (K Units)
Figure 19. Roxatidine Consumed in Stomach Ulcers
Figure 20. Global Roxatidine Market: Stomach Ulcers (2017-2022) & (K Units)
Figure 21. Roxatidine Consumed in Others
Figure 22. Global Roxatidine Market: Others (2017-2022) & (K Units)
Figure 23. Global Roxatidine Sales Market Share by Application (2017-2022)
Figure 24. Global Roxatidine Revenue Market Share by Application in 2021
Figure 25. Roxatidine Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Roxatidine Revenue Market Share by Company in 2021
Figure 27. Global Roxatidine Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Roxatidine Revenue Market Share by Geographic Region in 2021
Figure 29. Global Roxatidine Sales Market Share by Region (2017-2022)
Figure 30. Global Roxatidine Revenue Market Share by Country/Region in 2021
Figure 31. Americas Roxatidine Sales 2017-2022 (K Units)
Figure 32. Americas Roxatidine Revenue 2017-2022 ($ Millions)
Figure 33. APAC Roxatidine Sales 2017-2022 (K Units)
Figure 34. APAC Roxatidine Revenue 2017-2022 ($ Millions)
Figure 35. Europe Roxatidine Sales 2017-2022 (K Units)
Figure 36. Europe Roxatidine Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Roxatidine Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Roxatidine Revenue 2017-2022 ($ Millions)
Figure 39. Americas Roxatidine Sales Market Share by Country in 2021
Figure 40. Americas Roxatidine Revenue Market Share by Country in 2021
Figure 41. United States Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Roxatidine Sales Market Share by Region in 2021
Figure 46. APAC Roxatidine Revenue Market Share by Regions in 2021
Figure 47. China Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Roxatidine Sales Market Share by Country in 2021
Figure 54. Europe Roxatidine Revenue Market Share by Country in 2021
Figure 55. Germany Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Roxatidine Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Roxatidine Revenue Market Share by Country in 2021
Figure 62. Egypt Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Roxatidine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Roxatidine in 2021
Figure 68. Manufacturing Process Analysis of Roxatidine
Figure 69. Industry Chain Structure of Roxatidine
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...